UT Southwestern Neurology & Neurotherapeutics

Neurology at UT Southwestern Medical Center became an independent department in 1966. The initial growth of the department and development of the residency program were under the leadership of Roger Rosenberg, MD, who served as chairman for 18 years. In 2002, Steve Cannon, MD, PhD, was appointed Professor and Chairman of Neurology. Under Dr. Cannon’s leadership, the department continued to develop and expand its educational, research, and clinical goals. Dr. Cannon is now Associate Dean of Medical Education. Mark Goldberg, MD, was appointed department chair in July of 2010.

Under Dr. Goldberg’s leadership, UT Southwestern's Department of Neurology launched a new initiative to seek effective treatments for brain diseases. In recognition of this mission, the department has been renamed the Department of Neurology and Neurotherapeutics, the first program in the country to be identified this way.

The Department of Neurology and Neurotherapeutics is building state-of the-art facilities for drug and device testing, and bringing current and new faculty together for collaborative research on brain disease therapy. Scientists will leverage historic institutional strengths in molecular biology, genetics, and neuroscience.